Control Bionics is thrilled to announce it has been awarded one of the prestigious ALS Association 2023 Assistive Technology Grants. The ALS Association is the leading ALS organization in the world and is working to make ALS a livable disease while urgently searching for new treatments and a cure. The grant enables Control Bionics to amplify our commitment to advancing technology that enhances communication, mobility, and independence for people living with ALS.
Control Bionics’ ALS Association-funded work introduces DROVE to the USA. DROVE is an autonomous driving wheelchair module created to give users the ability to independently navigate in their home. With a variety of access methods, users can select a pre-defined destination on an augmentative and alternative communication (AAC) system, removing the need for the user to physically navigate tight corridors and doorways at home.
At Control Bionics, we’re not just creating assistive devices; we’re shaping a future where ALS doesn’t hinder living fully. Together, we will continue to champion resilience and empowerment in the face of adversity.
